Akihiro Kitadate (A Kitadate)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 10

Top Topics

Chronic Lymphocytic Leukemia

Computed Tomography

Multiple Myeloma

Top Venues

Cancer medicine

Journal of cutaneous pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Ko Abe, Sho Ikeda, Miho Nara, Akihiro Kitadate, Hiroyuki Tagawa, Naoto Takahashi
Hypoxia-induced oxidative stress promotes therapy resistance via upregulation of heme oxygenase-1 in multiple myeloma. Cancer medicine (2023)
Wataru Kuroki, Akihiro Kitadate, Koichi Ishiyama, Yoshihiro Kameoka, Naoto Takahashi
High baseline total lesion glycolysis predicts early progression of disease within 24 months in patients with high-tumor-burden follicular lymphoma. International journal of hematology 116 (5) (2022)
Yuka Matsuda, Sho Ikeda, Fumito Abe, Yuto Takahashi, Akihiro Kitadate, Naoto Takahashi, Hideki Wakui, Hiroyuki Tagawa
Downregulation of miR-26 promotes invasion and metastasis via targeting interleukin-22 in cutaneous T-cell lymphoma. Cancer science 113 (4) (2022)
Akihiro Kitadate, Toshiki Terao, Kentaro Narita, Sho Ikeda, Yuto Takahashi, Takafumi Tsushima, Daisuke Miura, Masami Takeuchi, Naoto Takahashi, Matsue Kosei
Multiple myeloma with t(11;14)-associated immature phenotype has lower CD38 expression and higher BCL2 dependence. Cancer science 112 (9) (2021)
Toshiki Terao, Youichi Machida, Takafumi Tsushima, Daisuke Miura, Kentaro Narita, Akihiro Kitadate, Masami Takeuchi, Matsue Kosei
Pre-treatment metabolic tumour volume and total lesion glycolysis are superior to conventional positron-emission tomography/computed tomography variables for outcome prediction in patients with newly diagnosed multiple myeloma in clinical practice. British journal of haematology 191 (2) (2020)
Matsue Kosei, Yoshiaki Abe, Kentaro Narita, Hiroki Kobayashi, Akihiro Kitadate, Daisuke Miura, Masami Takeuchi, Kengo Takeuchi
Bone marrow infiltration pattern in patients with intravascular large B-cell lymphoma diagnosed by random skin biopsy. EJHaem 1 (1) (2020)
Akihiro Kitadate, Kentaro Narita, Kouta Fukumoto, Toshiki Terao, Takafumi Tsushima, Hiroki Kobayashi, Yoshiaki Abe, Daisuke Miura, Masami Takeuchi, Youichi Machida, Matsue Kosei
Baseline total lesion glycolysis combined with interim positron emission tomography-computed tomography is a robust predictor of outcome in patients with peripheral T-cell lymphoma. Cancer medicine 9 (15) (2020)
Hiroki Kobayashi, Toshiki Terao, Takafumi Tsushima, Yoshiaki Abe, Daisuke Miura, Kentaro Narita, Akihiro Kitadate, Masami Takeuchi, Matsue Kosei
Association between serum erythropoietin levels and renal reversibility in patients with renal impairment from multiple myeloma. Cancer medicine 9 (12) (2020)
Naoko Enzan, Akihiro Kitadate, Haru Suzuki, Miri Yoshioka, Kentaro Narita, Atsushi Tanaka, Kosei Matsue
Intravascular large B-cell lymphoma diagnosed by incisional random skin biopsy after failure of diagnosis using punch biopsy: A case report. Journal of cutaneous pathology 48 (4) (2020)
N Enzan, Akihiro Kitadate, A Tanaka, K Matsue
Incisional random skin biopsy, not punch biopsy, is an appropriate method for diagnosis of intravascular large B-cell lymphoma: a clinicopathological study of 25 patients. The British journal of dermatology 181 (1) (2019)